BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25196286)

  • 1. Germline polymorphisms and survival of lung adenocarcinoma patients: a genome-wide study in two European patient series.
    Galvan A; Colombo F; Frullanti E; Dassano A; Noci S; Wang Y; Eisen T; Matakidou A; Tomasello L; Vezzalini M; Sorio C; Dugo M; Ambrogi F; Iacobucci I; Martinelli G; Incarbone M; Alloisio M; Nosotti M; Tosi D; Santambrogio L; Pelosi G; Pastorino U; Houlston RS; Dragani TA
    Int J Cancer; 2015 Mar; 136(5):E262-71. PubMed ID: 25196286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
    Lee Y; Yoon KA; Joo J; Lee D; Bae K; Han JY; Lee JS
    Carcinogenesis; 2013 Feb; 34(2):307-13. PubMed ID: 23144319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study of survival in patients with pancreatic adenocarcinoma.
    Wu C; Kraft P; Stolzenberg-Solomon R; Steplowski E; Brotzman M; Xu M; Mudgal P; Amundadottir L; Arslan AA; Bueno-de-Mesquita HB; Gross M; Helzlsouer K; Jacobs EJ; Kooperberg C; Petersen GM; Zheng W; Albanes D; Boutron-Ruault MC; Buring JE; Canzian F; Cao G; Duell EJ; Elena JW; Gaziano JM; Giovannucci EL; Hallmans G; Hutchinson A; Hunter DJ; Jenab M; Jiang G; Khaw KT; LaCroix A; Li Z; Mendelsohn JB; Panico S; Patel AV; Qian ZR; Riboli E; Sesso H; Shen H; Shu XO; Tjonneland A; Tobias GS; Trichopoulos D; Virtamo J; Visvanathan K; Wactawski-Wende J; Wang C; Yu K; Zeleniuch-Jacquotte A; Chanock S; Hoover R; Hartge P; Fuchs CS; Lin D; Wolpin BM
    Gut; 2014 Jan; 63(1):152-60. PubMed ID: 23180869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the CHRNA3 locus with lung cancer risk and prognosis in Chinese Han population.
    Niu X; Chen Z; Shen S; Liu Y; Zhou D; Zhang J; Li Z; Yu Y; Liao M; Lu S; He L
    J Thorac Oncol; 2010 May; 5(5):658-66. PubMed ID: 20234319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exome-Wide Association Study Identifies Low-Frequency Coding Variants in 2p23.2 and 7p11.2 Associated with Survival of Non-Small Cell Lung Cancer Patients.
    Zhu M; Geng L; Shen W; Wang Y; Liu J; Cheng Y; Wang C; Dai J; Jin G; Hu Z; Ma H; Shen H
    J Thorac Oncol; 2017 Apr; 12(4):644-656. PubMed ID: 28104536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib.
    Zhang L; Yuan X; Chen Y; Du XJ; Yu S; Yang M
    Gene; 2013 Mar; 517(1):60-4. PubMed ID: 23313300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer.
    Schabath MB; Giuliano AR; Thompson ZJ; Amankwah EK; Gray JE; Fenstermacher DA; Jonathan KA; Beg AA; Haura EB
    Carcinogenesis; 2013 Nov; 34(11):2525-30. PubMed ID: 23839018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival.
    Dai J; Jin G; Dong J; Chen Y; Xu L; Hu Z; Shen H
    J Thorac Oncol; 2010 Nov; 5(11):1748-54. PubMed ID: 20881643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma.
    Enokida Y; Shimizu K; Atsumi J; Kakegawa S; Takase Y; Kaira K; Yashima H; Araki T; Nakazawa S; Ohtaki Y; Nagashima T; Alexander L; Usui K; Ishikawa T; Hayashizaki Y; Takeyoshi I
    Cancer Med; 2016 Aug; 5(8):1791-801. PubMed ID: 27228500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
    Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
    J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA cMras inhibits lung adenocarcinoma progression via modulating miR-567/PTPRG regulatory pathway.
    Yu C; Tian F; Liu J; Su M; Wu M; Zhu X; Qian W
    Cell Prolif; 2019 May; 52(3):e12610. PubMed ID: 31012177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.
    Santarpia M; Ramirez JL; de Aguirre I; Garrido P; PĂ©rez Cano M; Queralt C; Gonzalez-Larriba JL; Insa A; Provencio M; Isla D; Camps C; Blanco R; Moran T; Rosell R;
    Clin Lung Cancer; 2017 Mar; 18(2):178-188.e4. PubMed ID: 27908619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variations associated with postoperative recurrence in stage I non-small cell lung cancer.
    Yoon KA; Jung MK; Lee D; Bae K; Joo JN; Lee GK; Lee HS; Lee JS
    Clin Cancer Res; 2014 Jun; 20(12):3272-9. PubMed ID: 24737549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer.
    Liu Y; Kheradmand F; Davis CF; Scheurer ME; Wheeler D; Tsavachidis S; Armstrong G; Simpson C; Mandal D; Kupert E; Anderson M; You M; Xiong D; Pikielny C; Schwartz AG; Bailey-Wilson J; Gaba C; De Andrade M; Yang P; Pinney SM; ; Amos CI; Spitz MR
    J Thorac Oncol; 2016 Jan; 11(1):52-61. PubMed ID: 26762739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variant of Notch Regulator DTX1 Predicts Survival After Lung Cancer Surgery.
    Lee JH; Shin KM; Lee SY; Hong MJ; Choi JE; Kang HG; Do SK; Lee WK; Lee EB; Seok Y; Jeong JY; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Kim YC; Oh IJ; Na KJ; Kim MS; Lee JM; Yang HC; Jung CY; Park CK; Lee MK; Kim DK; Park JY
    Ann Surg Oncol; 2019 Oct; 26(11):3756-3764. PubMed ID: 31313037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
    Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
    PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple genetic loci modulate lung adenocarcinoma clinical staging.
    Frullanti E; Galvan A; Falvella FS; Manenti G; Colombo F; Vannelli A; Incarbone M; Alloisio M; Nosotti M; Santambrogio L; Gonzalez-Neira A; Pastorino U; Dragani TA
    Clin Cancer Res; 2011 Apr; 17(8):2410-6. PubMed ID: 21242121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
    Niu N; Schaid DJ; Abo RP; Kalari K; Fridley BL; Feng Q; Jenkins G; Batzler A; Brisbin AG; Cunningham JM; Li L; Sun Z; Yang P; Wang L
    BMC Cancer; 2012 Sep; 12():422. PubMed ID: 23006423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of functional LIG4 polymorphism on platinum-based chemotherapy response and survival in non-small cell lung cancer.
    Jiang YH; Xu XL; Ruan HH; Xu WZ; Li D; Feng JG; Han QB; Mao WM
    Med Oncol; 2014 May; 31(5):959. PubMed ID: 24722796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common polymorphisms in D12S1034 flanking genes RASSF8 and BHLHB3 are not associated with lung adenocarcinoma risk.
    Falvella FS; Spinola M; Manenti G; Conti B; Pastorino U; Skaug V; Haugen A; Dragani TA
    Lung Cancer; 2007 Apr; 56(1):1-7. PubMed ID: 17194498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.